Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection
暂无分享,去创建一个
R. Haubrich | D. Havlir | J. Mellors | S. Riddler | H. Ribaudo | K. Klingman | J. Rooney | K. Garren | D. Butcher | G. Direnzo